Hypertension, commonly known as High Blood Pressure (HBP), is a chronic medical condition where the force of the blood against your artery walls is consistently too high. In 2026, it remains the leading modifiable risk factor for cardiovascular disease globally, often called a “Silent Killer” because many people have no symptoms until significant organ damage occurs.
1. Understanding the Numbers (2026 Guidelines)
Blood pressure is measured using two numbers: Systolic (pressure when the heart beats) and Diastolic (pressure when the heart rests).
| Category | Systolic (Top Number) | Diastolic (Bottom Number) |
| Normal | Less than $120$ mmHg | Less than $80$ mmHg |
| Elevated | $120$ – $129$ mmHg | Less than $80$ mmHg |
| Stage 1 Hypertension | $130$ – $139$ mmHg | $80$ – $89$ mmHg |
| Stage 2 Hypertension | $140$ mmHg or higher | $90$ mmHg or higher |
| Hypertensive Crisis | Higher than $180$ mmHg | Higher than $120$ mmHg |
2. Types and Causes
Primary (Essential) Hypertension: For $90\%–95\%$ of adults, there is no single identifiable cause. It develops gradually over years due to a mix of genetics, aging, and lifestyle factors.
Secondary Hypertension: Caused by an underlying condition (e.g., kidney disease, thyroid problems, or adrenal gland tumors). It often appears suddenly and causes higher blood pressure than primary hypertension.
3. The Indian Landscape in 2026
India is currently undergoing a rapid epidemiological transition. As of April 2026:
Prevalence: Nearly $1$ in $3$ adults in India are hypertensive.
The Rural Shift: Recent 2026 data shows that rural areas (like Tamil Nadu) have seen a significant rise in prevalence ($29.8\%$) as lifestyle patterns converge with urban centers.
The “Rule of Halves”: Roughly half of those with hypertension are unaware of it; half of those aware are on treatment; and only about half of those on treatment have their blood pressure controlled.
4. Why Healthy Inc. is Your Strategic Partner in Hypertension Management
Managing the hypertension epidemic requires a reliable supply of high-quality Antihypertensives. Healthy Inc. acts as your professional gateway to India’s manufacturing excellence.
Strategic Sourcing Hub: We are associated with multiple state-of-the-art units specializing in cardiovascular health. Whether you need Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers (CCBs), or Thiazide Diuretics, we match you with the facility holding the best stability data.
Pharmacist-Led Technical Vetting: We provide “straight answers” on Fixed-Dose Combinations (FDCs). In 2026, guidelines strongly recommend starting Stage 2 patients on two medications in a single pill to improve compliance. We vet these complex formulations for maximum efficacy.
Regulatory & Dossier Mastery: We simplify international registration with full CTD/ACTD dossiers, ensuring your products meet the latest 2026 WHO-GMP and international standards for global tenders.
Market-Ready Solutions: Through our network, we offer flexible Private Labeling (OEM), allowing you to launch trusted cardiovascular brands that meet the specific demographic needs of your market.
Showing all 11 results
Imidapril Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for precise titration). The standard strengths are optimized for maintenance therapy.
Active Ingredient Strength (Standard) Role Imidapril HCl 5 mg Initial Dose / Renal Impairment Imidapril HCl 10 mg Standard Maintenance Dose Excipients Q.S. Lactose / Macrogol Indapamide Tablets
FreeProduct Composition & Strength
We supply this product as Sugar/Film Coated Tablets (Immediate Release) or Sustained Release (SR) Tablets.
Active Ingredient Strength Formulation Role Indapamide USP/BP 1.5 mg Sustained Release (SR) Modern Standard Dose (24hr Control) Indapamide USP/BP 2.5 mg Immediate Release Classic Maintenance Dose Excipients Q.S. HPMC (Matrix) / Lactose Release Control Lisinopril Tablet
FreeProduct Composition & Available Portfolio Range
We manufacture Lisinopril in exact, compendial strengths calibrated to support initial introductory titration up to high-potency cardioprotective maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lisinopril Anhydrous / Dihydrate USP / BP / IP 5 mg Oral Solid Uncoated Tablet Initial Titration: For low-dose introductory management, pediatric hypertension, or initial combination therapy initiation. Lisinopril Anhydrous / Dihydrate USP / BP / IP 10 mg Oral Solid Uncoated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Lisinopril Anhydrous / Dihydrate USP / BP / IP 20 mg Oral High-Potency Solid Tablet Advanced Cardioprotection: High-strength configuration calibrated for severe heart failure management and post-infarction survival optimization. Methyldopa Tablet
FreeProduct Composition & Available Strengths
We supply Methyldopa in standard, exact strengths designed to facilitate the careful, progressive dose titration required in gestational healthcare.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Methyldopa Anhydrous IP / BP / USP 250 mg Oral Solid Film-Coated Tablet (Scored for micro-titration) Initial Titration / Baseline Care: For early-stage gestational hypertension and lower-dose fine-tuning. Methyldopa Anhydrous IP / BP / USP 500 mg Oral Solid Film-Coated Tablet (Engineered for uniform mass release) High-Potency Maintenance: For advanced chronic hypertension during pregnancy and severe pre-eclamptic stabilization. Nicoumalone Tablet
FreeProduct Composition & Calibration Spectrum
We manufacture Nicoumalone in a complete, highly precise range of strengths to allow for the exact dosage adjustments required to maintain narrow therapeutic targets.
Active Ingredient Common Name Compendial Monograph Available Strengths Primary Clinical Application Nicoumalone (Acenocoumarol) BP / IP / USP 1 mg Micro-Titration Phase: For delicate, low-dose fine-tuning in geriatric or sensitive patient profiles. Nicoumalone (Acenocoumarol) BP / IP / USP 2 mg Foundational Maintenance: The standard baseline dose for routine daily thromboembolic prophylaxis. Nicoumalone (Acenocoumarol) BP / IP / USP 3 mg Intermediate Control: For patients requiring step-up adjustment to hit targeted coagulation thresholds. Nicoumalone (Acenocoumarol) BP / IP / USP 4 mg High-Threshold Suppression: For rapid oral loading or patients presenting high chemical resistance to standard doses. Nifedipine Tablet
FreeProduct Composition & Structural Formats
We manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.
Active Ingredient Available Strengths Formulation Matrix Delivery System Primary Clinical Focus Nifedipine IP/BP/USP 10 mg Immediate-Release / Rapid-Onset Film Tablet Acute Titration / Tocolysis: For severe acute hypertension or suppression of premature labor contractions. Nifedipine IP/BP/USP 20 mg Sustained-Release (SR) Retard Matrix Twice-Daily Maintenance: Intermediate control for stable chronic hypertension. Nifedipine IP/BP/USP 30 mg Once-Daily Extended-Release (XR / XL) Matrix First-Line Chronic Care: Continuous 24-hour plasma stabilization for mild-to-moderate hypertension. Nifedipine IP/BP/USP 60 mg Once-Daily Extended-Release (XR / XL) Matrix High-Potency Control: For refractory essential hypertension and severe chronic stable angina pectoris. Phenobarbital Tablets
FreePhenobarbitone Tablets IP
Each Uncoated tablet contains :
Phenobarbitone IP 30 mg
Excipients q.sPhenobarbitone Tablets IP 60 mg
Phenobarbital Tablets IP 60 mg
Each Uncoated tablet contains :
Phenobarbitone IP 60 mg
Phenobarbital
Excipients q.sPhenobarbital Tablets BP
Each Uncoated tablet contains :
Phenobarbital BP 30 mgPhenobarbital Tablets BP 60 mg
Each Uncoated tablet contains :
Phenobarbital BP 60 mg Excipients q.sPHENOBARBITAL TABLETS BP 90 MG Each Uncoated tablet contains : Phenobarbital BP 90 mg
Excioients 0 QSPhenobarbital Tablets BP 100 mg
Each Uncoated tablet contains :
Phenobarbital BP 100 mg Excipients -QSUsage: – To control seizures
Category: – Anti Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
Prazosin Tablets
FreePrazosin Tablets IP 2 mg
Each filmcoated tablet contains:
Prazosin Hydrochloride IP
Eq to Prazosin 2 mgPRAZOSIN TABLETS IP 2.5 MG Each film coated Tablet Contains:
Prazosin hydrochloride IP equivalent to prazosin 2.5 mg Excipients q.s.PRAZOSIN TABLETS IP 5 MG Each film coated Tablet Contains:
Prazosin hydrochloride IP equivalent to prazosin 5 mg Excipients q.s.Usage: – Treat high blood pressure
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Propranolol Tablets
FreePropranolol Tablets BP 10 mg
Each Uncoated Tablet Contains:
Propranolol Hydrochloride BP 10 mgCIRPROL / TABLETS/PROPRANOLOL TABLETS BP 40 MG
Each uncoated tablet contains: Propranolol Hydrochloride BP 40 MGUsage: – High blood pressure. Treat illnesses
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Sodium Valproate & Valproic Acid Tablets
FreeProduct Composition & Strength
We supply this product as Controlled Release (CR) / Chrono Tablets to ensure stable blood levels over 24 hours.
Product Strength Sodium Valproate Valproic Acid Total Valproate 200 mg CR 133 mg 58 mg ~200 mg 300 mg CR 200 mg 87 mg ~300 mg 500 mg CR 333 mg 145 mg ~500 mg Enteric Coated 200/500 mg (Sodium Valproate Only) Standard Release Warfarin Tablets
FreeProduct Composition & Strengths
We supply this product in standardized, color-coded strengths to ensure precise dose titration, which is physically critical for this medication.
Active Ingredient Strength Primary Clinical Target Warfarin Sodium IP/BP/USP 1 mg Micro-Titration: For fine-tuned adjustments. Warfarin Sodium IP/BP/USP 2 mg Standard Maintenance: For stable anticoagulation. Warfarin Sodium IP/BP/USP 5 mg High Dose: For initial loading or resistant cases.
